Stockscreener 앱 받기
7.03
0.14%
0.01
전일 마감가:
$7.02
열려 있는:
$6.9
하루 거래량:
10,049
Relative Volume:
0.05
시가총액:
$3.99M
수익:
$49,300
순이익/손실:
$-6.27M
주가수익비율:
-0.7734
EPS:
-9.09
순현금흐름:
$-5.38M
1주 성능:
+2.70%
1개월 성능:
-35.03%
6개월 성능:
+41.97%
1년 성능:
-10.86%
1일 변동 폭
$6.78
$7.15
1주일 범위
$6.20
$7.235
52주 변동 폭
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
ACON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
7.04 | 3.99M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
238.54 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.47 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.86 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
92.10 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.35 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Welcomes Advocate Health as CLARITY Trial Site - The Manila Times
Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan
Aclarion secures funding for pivotal CLARITY trial - MSN
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News
Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus
Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks
Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq
Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan
Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Aclarion Inc Files For Mixed Shelf Of Up To $150 MlnSEC Filing - marketscreener.com
Aclarion Releases Updated Investor Presentation at Showcase - TipRanks
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - The Manila Times
Aclarion, Inc. to Present at Planet MicroCap Showcase: VEGAS 2025 on Chronic Low Back Pain Solutions - Nasdaq
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet ... - Bluefield Daily Telegraph
Aclarion's Revolutionary AI Approach to Chronic Back Pain: New Investor Strategy Revealed at MicroCap Vegas - Stock Titan
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - Ortho Spine News
Aclarion's Nociscan Demonstrates Cost-Effectiveness and Improved Surgical Success Compared to Provocative Discography - Nasdaq
New Research: AI-Powered Spine Technology Cuts Patient Costs by $1,712, Boosts Surgery Success 10% - Stock Titan
NOCISCAN touted as lumbar pain diagnostic advance - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - The Manila Times
Aclarion, Inc. SEC 10-K Report - TradingView
Aclarion stock hits 52-week low at $9.68 amid steep annual decline - Investing.com Canada
Aclarion stock hits 52-week low at $9.68 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion ‘s Nociscan now available in Santa Monica at MICSC - TipRanks
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - The Manila Times
Revolutionary AI-Powered Back Pain Diagnostic Tool Gains Ground in Los Angeles Healthcare Market - Stock Titan
EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?Apple (NASDAQ:AAPL), Aclarion (NASDAQ:ACON) - Benzinga
Aclarion, Inc. Delays Annual Report Filing - TipRanks
Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives - Ortho Spine News
Aclarion provides corporate update following Q1 strategic initiatives - TipRanks
Aclarion, Inc. (NASDAQ:ACON) Short Interest Down 73.9% in March - Defense World
Aclarion stock plunges to 52-week low of $0.51 amid steep decline By Investing.com - Investing.com South Africa
Aclarion announces 1-for-27 reverse stock split By Investing.com - Investing.com South Africa
Aclarion Announces Reverse Stock Split - OrthoSpineNews
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings - Benzinga
Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga
Aclarion stock plunges to 52-week low of $0.51 amid steep decline - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Aclarion announces 1-for-27 reverese stock split - TipRanks
Aclarion announces 1-for-27 reverse stock split - Investing.com
Aclarion (ACON) to Release Earnings on Thursday - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.12%
2.25%
자본화:
|
볼륨(24시간):